Imagine trying to solve a crime when most of the evidence is invisible.
That’s what studying tick-borne disease can feel like. A tick no bigger than a sesame seed can carry bacteria, viruses, and parasites all at once. Some are well known. Others are emerging. Some are infectious. Others are only genetic traces left behind.
On the surface, testing a tick sounds simple. In reality, it’s a scientific puzzle layered with complexity.
A growing public health challenge
Tick-borne diseases are rising worldwide. In the United States alone, hundreds of thousands of Lyme disease cases are diagnosed each year. Climate change, land use shifts, and expanding tick habitats are reshaping risk maps.
But understanding true risk isn’t straightforward.
Ticks frequently carry multiple pathogens simultaneously. Traditional testing methods often look for one pathogen at a time. Low pathogen levels can evade detection. DNA-based tests may detect non-viable fragments, overstating risk. Genetic variability between strains adds yet another layer of difficulty.
To protect communities, surveillance needs to be faster, more sensitive, and more comprehensive.
Revvity is strengthening the research workflow from the start
Better answers begin with better preparation.
Ticks are tough by nature, literally. Their resilient outer shells make consistent lysis difficult, limiting DNA yield and slowing throughput. Traditional methods involve lengthy enzyme incubations, often overnight, that add an extensive amount of time to the sample prep workflow. Robust bead mill homogenization systems like the Omni Bead Ruptor Elite™ break through these barriers efficiently, reducing preparation time while improving consistency.
Automation then moves the process forward. Platforms such as the chemagic™ 360 enable high-throughput nucleic acid extraction with walk-away capability, minimizing human variability and increasing laboratory capacity.
Instead of manual bottlenecks, labs gain speed, reliability, and scale.
Seeing the full picture
Detection itself is evolving.
Multiplex PCR panels allow research laboratories to screen for multiple organisms in a single reaction, providing a broader view of organism burden while conserving valuable sample material. Rather than testing sequentially, researchers gain a more complete answer from each tick.
Next-generation sequencing and metagenomics extend this visibility even further, enabling discovery of emerging or previously unknown threats.
When combined with predictive modeling, machine learning, and ecological data, surveillance can shift from reactive to proactive.
From data to prevention
This is about more than detection.
More sensitive workflows mean earlier warning systems. More comprehensive surveillance enables clearer risk assessment. Faster, scalable processes help public health agencies act before outbreaks expand.
Bridging the gap in tick-borne disease research means connecting biology, automation, analytics, and real-world protection.
The threats may be small. The stakes are not.
Understanding what lies beneath the surface is one of the most important steps in protecting what matters most. Challenge accepted.
For research use only. Not for use in diagnostic procedures.
